Aptevo Therapeutics Inc. (APVO) Net margin 2016–2023
Aptevo Therapeutics Inc. (APVO) net profit margin by fiscal year — reported net income divided by reported revenue.
-559.1%FY2023 · since FY2016: -334.6% → -559.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -559.1% | -624.4 pp |
| FY2022 | 65.3% | +725.7 pp |
| FY2021 | -660.4% | -605.7 pp |
| FY2020 | -54.7% | +120.6 pp |
| FY2019 | -175.4% | +190.9 pp |
| FY2018 | -366.3% | -436.1 pp |
| FY2017 | 69.8% | +404.4 pp |
| FY2016 | -334.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More APVO financial trends
APVO RevenueAPVO Net incomeAPVO Gross profitAPVO Gross marginAPVO Operating incomeAPVO Operating marginAPVO Operating cash flowAPVO Free cash flowAPVO Capital expendituresAPVO Return on equityAPVO Stock buybacksAPVO Dividends paidAPVO Total assetsAPVO Total liabilitiesAPVO Shareholders’ equityAPVO overview →